Here are the latest quarterly results of GSK Pharma. For more details, see the GSK Pharma financial fact sheet and GSK Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Dec-18 |
3
Mar-19 |
3
Jun-19 |
3
Sep-19 |
3
Dec-19 |
3
Mar-20 |
3
Jun-20 |
3
Sep-20 |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 8,254 | 7,512 | 7,880 | 8,821 | 7,787 | 7,759 | 6,487 | 8,794 | |
Other income | Rs m | 164 | 525 | 305 | 156 | 163 | 152 | 578 | 89 | |
Turnover | Rs m | 8,418 | 8,037 | 8,186 | 8,977 | 7,949 | 7,910 | 7,064 | 8,883 | |
Expenses | Rs m | 6,880 | 5,876 | 6,225 | 6,879 | 6,540 | 6,018 | 5,343 | 6,744 | |
Gross profit | Rs m | 1,655 | 1,605 | 1,655 | 5,954 | -6,123 | 1,854 | 1,144 | 1,409 | |
Depreciation | Rs m | 120 | 137 | 191 | 227 | 183 | 226 | 218 | 220 | |
Interest | Rs m | 1 | 1 | 9 | 9 | 30 | 15 | 11 | 9 | |
Profit before tax | Rs m | 1,698 | 1,992 | 1,760 | 5,874 | -6,173 | 1,764 | 1,493 | 1,270 | |
Tax | Rs m | 568 | 761 | 626 | 846 | 268 | 385 | 383 | 505 | |
Profit after tax | Rs m | 1,130 | 1,230 | 1,135 | 5,028 | -6,441 | 1,379 | 1,110 | 765 | |
Gross profit margin | % | 20.0 | 21.4 | 21.0 | 67.5 | -78.6 | 23.9 | 17.6 | 16.0 | |
Effective tax rate | % | 33.5 | 38.2 | 35.5 | 14.4 | -4.3 | 21.8 | 25.7 | 39.7 | |
Net profit margin | % | 13.7 | 16.4 | 14.4 | 57.0 | -82.7 | 17.8 | 17.1 | 8.7 | |
Diluted EPS | Rs | 6.7 | 7.3 | 6.7 | 29.7 | -38.0 | 8.1 | 6.5 | 4.5 | |
Diluted EPS (TTM) | Rs | 24.1 | 25.1 | 26.6 | 50.3 | 5.6 | 6.5 | 6.3 | -18.8 | |
![]() |
Read: GSK Pharma 2QFY21 Result Performance Review
More Pharmaceuticals Company Quarterly Results: VENUS REMEDIES SUVEN LIFE SCIENCES NOVARTIS AUROBINDO PHARMA WOCKHARDT
Compare GSK PHARMA With: VENUS REMEDIES SUVEN LIFE SCIENCES NOVARTIS AUROBINDO PHARMA WOCKHARDT
Compare GSK PHARMA With: MYLAN (US) ACTAVIS (US) ADCOCK INGRAM (S. Africa) TEVA PHARMA (Israel)
Asian share markets are trading on a mixed note today. The Nikkei is trading lower by 0.5% and the Hang Seng is trading up by 0.2%.
For the quarter ended September 2020, GSK PHARMA has posted a net profit of Rs 765 m (down 84.8% YoY). Sales on the other hand came in at Rs 9 bn (down 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.
For the quarter ended June 2020, GSK PHARMA has posted a net profit of Rs 1 bn (down 2.2% YoY). Sales on the other hand came in at Rs 6 bn (down 17.7% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.
Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.
More Views on NewsThe smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.
The charts are telling the bulls to be cautious.
Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
Our ace stock picker is ready to capitalise on a big growth opportunity.
More